Pages that link to "Q37048793"
Jump to navigation
Jump to search
The following pages link to Triple negative tumours: a critical review (Q37048793):
Displaying 50 items.
- Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool? (Q21261291) (← links)
- Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer (Q24654216) (← links)
- Understanding the role of the kynurenine pathway in human breast cancer immunobiology (Q26773472) (← links)
- MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer (Q26775086) (← links)
- Biomarkers in triple negative breast cancer: A review (Q26775094) (← links)
- A recapitulative three-dimensional model of breast carcinoma requires perfusion for multi-week growth (Q26779577) (← links)
- Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis (Q26823419) (← links)
- A perspective on anti-EGFR therapies targeting triple-negative breast cancer (Q28069867) (← links)
- Estrogen-Related Receptors in Breast Cancer and Prostate Cancer (Q28084030) (← links)
- miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer (Q28115315) (← links)
- Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer (Q28387216) (← links)
- Novel genes associated with lymph node metastasis in triple negative breast cancer (Q28393204) (← links)
- Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer (Q29248648) (← links)
- The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer (Q30417120) (← links)
- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status (Q30496322) (← links)
- An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer. (Q33355327) (← links)
- Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer (Q33415281) (← links)
- A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer (Q33420154) (← links)
- Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors (Q33483633) (← links)
- Pea3 transcription factors and wnt1-induced mouse mammary neoplasia (Q33526975) (← links)
- Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review (Q33553668) (← links)
- Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study (Q33596695) (← links)
- Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study (Q33613662) (← links)
- Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions (Q33625453) (← links)
- Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype (Q33710233) (← links)
- FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer. (Q33710341) (← links)
- Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer. (Q33712426) (← links)
- Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. (Q33723629) (← links)
- Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells (Q33726477) (← links)
- Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. (Q33739233) (← links)
- Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells. (Q33750192) (← links)
- Age-associated prognostic and predictive biomarkers in patients with breast cancer (Q33750880) (← links)
- Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis (Q33751806) (← links)
- High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients (Q33762138) (← links)
- The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment (Q33776899) (← links)
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets (Q33780945) (← links)
- Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway (Q33820727) (← links)
- Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. (Q33825671) (← links)
- alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies. (Q33830446) (← links)
- Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients (Q33842913) (← links)
- Breast cancer proteomics: a review for clinicians (Q33862872) (← links)
- Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry (Q33864102) (← links)
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes (Q33874621) (← links)
- Novel therapeutic strategies in the treatment of triple-negative breast cancer (Q33887682) (← links)
- Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis (Q33994291) (← links)
- Genomic instability in breast cancer: pathogenesis and clinical implications (Q33998514) (← links)
- p16INK4a expression in basal-like breast carcinoma. (Q34007463) (← links)
- Mammary gland growth factors: roles in normal development and in cancer (Q34014659) (← links)
- Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines (Q34060031) (← links)
- Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis (Q34077422) (← links)